.jpg?format=webp&quality=80&width=3840)
This study aimed to investigate the effects of aspirin on mean arterial pressure (MAP) and mean uterine artery pulsatility index (UtPI) in women at increased risk of preterm pre-eclampsia. The study used data from the ASPRE trial, in which 1,620 women were identified at increased risk of preterm pre-eclampsia and randomly assigned to receive aspirin or placebo. MAP and UtPI were measured at baseline and follow-up visits. The study found that aspirin did not affect MAP but was associated with a significant decrease in mean UtPI, particularly before 20 weeks of gestation.
Like
Save
Share